PURPOSE: To determine the intervisit variability of kinetic visual fields and visual acuity in patients with Leber congenital amaurosis (LCA) caused by mutations in the RPE65 (Retinal Pigment Epithelium-specific protein 65kDa) gene. METHODS: RPE65-LCA patients (n = 20; ages 11-40 years) were studied on at least two visits separated by fewer than 120 days using Goldmann visual field (GVF) and ETDRS visual acuity (VA) in a retrospective review. GVFs were quantified by computing the spherical coordinates of their vertices and calculating the solid angle subtended, and reported in normalized solid-angle units (nsu) as a percentage of average normal field extent. Repeatability coefficients were calculated using 95% confidence intervals on log(10)-converted variables. RESULTS: Visual field extents in RPE65-LCA spanned a wide range from 4 to 95 nsu. The repeatability coefficient was 0.248 (log(10)nsu), suggesting cutoffs for significant change (in nsu) of +77% for improvement and -44% for worsening. VA in RPE65-LCA ranged from logMAR = 0.14 to 1.96 (20/40 to 20/1250). The repeatability coefficient was 0.170 (logMAR) (±8.5 ETDRS letters). Comparisons with published studies of ungenotyped retinitis pigmentosa showed that the RPE65-LCA patients had higher variability in kinetic field extent. VA variability in RPE65-LCA fell within reported results for retinitis pigmentosa. CONCLUSIONS: Variability data for GVF and VA are provided to permit interpretation of the significance of increases and decreases of these functional outcomes in ongoing and planned clinical trials of therapy for LCA caused by RPE65 mutations.
PURPOSE: To determine the intervisit variability of kinetic visual fields and visual acuity in patients with Leber congenital amaurosis (LCA) caused by mutations in the RPE65 (Retinal Pigment Epithelium-specific protein 65kDa) gene. METHODS:RPE65-LCA patients (n = 20; ages 11-40 years) were studied on at least two visits separated by fewer than 120 days using Goldmann visual field (GVF) and ETDRS visual acuity (VA) in a retrospective review. GVFs were quantified by computing the spherical coordinates of their vertices and calculating the solid angle subtended, and reported in normalized solid-angle units (nsu) as a percentage of average normal field extent. Repeatability coefficients were calculated using 95% confidence intervals on log(10)-converted variables. RESULTS: Visual field extents in RPE65-LCA spanned a wide range from 4 to 95 nsu. The repeatability coefficient was 0.248 (log(10)nsu), suggesting cutoffs for significant change (in nsu) of +77% for improvement and -44% for worsening. VA in RPE65-LCA ranged from logMAR = 0.14 to 1.96 (20/40 to 20/1250). The repeatability coefficient was 0.170 (logMAR) (±8.5 ETDRS letters). Comparisons with published studies of ungenotyped retinitis pigmentosa showed that the RPE65-LCA patients had higher variability in kinetic field extent. VA variability in RPE65-LCA fell within reported results for retinitis pigmentosa. CONCLUSIONS: Variability data for GVF and VA are provided to permit interpretation of the significance of increases and decreases of these functional outcomes in ongoing and planned clinical trials of therapy for LCA caused by RPE65 mutations.
Authors: Daniel A Rosser; Simon N Cousens; Ian E Murdoch; Fred W Fitzke; David A H Laidlaw Journal: Invest Ophthalmol Vis Sci Date: 2003-08 Impact factor: 4.799
Authors: Tomas S Aleman; Samuel G Jacobson; John D Chico; Michele L Scott; Andy Y Cheung; Elizabeth A M Windsor; Masatoshi Furushima; T Michael Redmond; Jean Bennett; Krzysztof Palczewski; Artur V Cideciyan Journal: Invest Ophthalmol Vis Sci Date: 2004-04 Impact factor: 4.799
Authors: Michael P Barry; Ava K Bittner; Liancheng Yang; Rebecca Marcus; Mian Haris Iftikhar; Gislin Dagnelie Journal: Optom Vis Sci Date: 2016-07 Impact factor: 1.973
Authors: Artur V Cideciyan; Geoffrey K Aguirre; Samuel G Jacobson; Omar H Butt; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Sam Sadigh; William W Hauswirth Journal: Invest Ophthalmol Vis Sci Date: 2014-12-23 Impact factor: 4.799
Authors: Gabrielle D Lacy; Maria Fernanda Abalem; David C Musch; Kanishka T Jayasundera Journal: Ophthalmic Genet Date: 2020-02-26 Impact factor: 1.803
Authors: Claire S Barnes; Ronald A Schuchard; David G Birch; Gislin Dagnelie; Leah Wood; Robert K Koenekoop; Ava K Bittner Journal: Transl Vis Sci Technol Date: 2019-06-11 Impact factor: 3.283
Authors: Brett G Jeffrey; Catherine A Cukras; Susan Vitale; Amy Turriff; Kristin Bowles; Paul A Sieving Journal: Transl Vis Sci Technol Date: 2014-10-03 Impact factor: 3.283
Authors: Xunda Luo; Artur V Cideciyan; Alessandro Iannaccone; Alejandro J Roman; Lauren C Ditta; Barbara J Jennings; Svetlana A Yatsenko; Rebecca Sheplock; Alexander Sumaroka; Malgorzata Swider; Sharon B Schwartz; Bernd Wissinger; Susanne Kohl; Samuel G Jacobson Journal: PLoS One Date: 2015-04-24 Impact factor: 3.240
Authors: Mays Talib; Mary J van Schooneveld; Roos J G van Duuren; Caroline Van Cauwenbergh; Jacoline B Ten Brink; Elfride De Baere; Ralph J Florijn; Nicoline E Schalij-Delfos; Bart P Leroy; Arthur A Bergen; Camiel J F Boon Journal: Transl Vis Sci Technol Date: 2019-08-19 Impact factor: 3.283
Authors: Manzar Ashtari; Laura Cyckowski; Alborz Yazdi; Amanda Viands; Kathleen Marshall; István Bókkon; Albert Maguire; Jean Bennett Journal: PLoS One Date: 2014-01-21 Impact factor: 3.752
Authors: Hendrik P N Scholl; Anthony T Moore; Robert K Koenekoop; Yuquan Wen; Gerald A Fishman; L Ingeborgh van den Born; Ava Bittner; Kristen Bowles; Emily C Fletcher; Frederick T Collison; Gislin Dagnelie; Simona Degli Eposti; Michel Michaelides; David A Saperstein; Ronald A Schuchard; Claire Barnes; Wadih Zein; Ditta Zobor; David G Birch; Janine D Mendola; Eberhart Zrenner Journal: PLoS One Date: 2015-12-10 Impact factor: 3.240